Testing

COVID-19 testing coverage a differentiator for health startup Bind

Via Bind “With Bind, premiums cover core medical services — including most diagnostic testing — with no deductible to meet first, Miller said. That means consumers with Bind coverage pay nothing to get tested for COVID-19.” “Most deductible plans, however, could not cover COVID-19 testing for consumers who had yet to meet their deductibles, Miller […]

A Handheld Device to Quickly Detect COVID-19

Via University of Minnesota “The MagiCoil starts with a tube containing tiny, magnetic iron oxide nanoparticles suspended in fluid. The nanoparticles have been coated with molecules of, for example, antibodies that recognize and stick to pieces of protein unique to the SARS-CoV-2 virus.” “The test involves adding a sample of blood or respiratory material, along […]

Abbott Announces Health Canada Authorization Under the COVID-19 Interim Order and Immediate Availability of its COVID-19 Antibody Test in Canada

Via Abbott Abbott (NYSE: ABT) announced today it received Health Canada authorization under the COVID-19 Interim Order* for the ARCHITECT SARS-CoV-2 IgG test, a laboratory-based serology blood test for the detection of the antibody, IgG, that identifies if a person has had the novel coronavirus (COVID-19). Antibody testing is an important next step to tell […]

Osterholm Update: COVID-19

Via University of Minnesota In this episode, Dr. Osterholm and host Chris Dall discuss the concept of smart testing, the risk of transmission outdoors, reports of children developing an inflammatory condition following infection with COVID-19, and the CDC’s role in this pandemic. Listen to the latest episode of Dr. Michael Osterholm’s podcast or read the […]

ABBOTT RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR COVID-19 MOLECULAR TEST ON NEW ALINITY™ M SYSTEM

Via Abbott Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the company’s molecular test for the novel coronavirus (COVID-19) for use on its new Alinity™ m molecular laboratory instrument. Abbott is in the process of launching the Alinity m system to U.S. customers. The Alinity m […]

ABBOTT RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR COVID-19 ANTIBODY BLOOD TEST ON ALINITY™ I SYSTEM

Via Abbott Abbott announced today that the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the company’s SARS-CoV-2 IgG lab-based serology blood test on the Alinity™ i system. Abbott plans to ship nearly 30 million antibody tests globally in May across its ARCHITECT® and Alinity i™ platforms and will have capacity for 60 million […]

New antibody test will help state reopen

Via University of Minnesota Researchers at the University of Minnesota Medical School have developed a test for antibodies to the SARS-CoV-2 virus—the agent that causes COVID-19—that uses routine laboratory supplies not in high demand.  In concert with the U of M’s PCR (polymerase chain reaction, a technique to detect specific DNA or RNA sequences) test […]

New Abbott antibody test wins CE Mark in Europe

Via Mass Device “Reports in the United Kingdom say that a 99% accurate COVID-19 antibody test produced by Abbott (NYSE:ABT) won CE Mark approval for use across Europe.” “The Abbott Park, Ill.-based company, which has a base in Maidenhead, England, expects to have shipped millions of its lab-based tests across Europe by the end of May, according […]

At The Table – April 2020

Minnesota’s Economic Outlook In the time since our March update, Minnesota’s legislative leaders called for more clarity on the state’s economic situation to inform their work. However, the state’s budget remains unclear in large part because the U.S. economic outlook continues to be profoundly negative. In February, the state budget forecast projected a $1.5 billion […]

Gov. Tim Walz announces plan to expand COVID-19 testing

Via Star Tribune “Gov. Tim Walz announced a new statewide pandemic strategy Wednesday, leveraging the University of Minnesota, Mayo Clinic and other state health care providers to increase COVID-19 diagnostic testing in the state to as many as 20,000 Minnesotans per day.” “The increased testing, announced at a news conference at the state’s emergency operations […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER